No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

Dr. Megan Coylewright Named Editor of CardioSmart

Editor: What To Know

  • “The role of editor of CardioSmart is an ideal blend of my daily clinical work performing transcatheter valve repair and replacement, research in shared decision making, and our community and nationally-based efforts to ensure we are using best practices in promoting diversity, inclusion and belonging in all that we do,” Coylewright said.
  • Trained as a structural interventional cardiologist, Coylewright is the vice chief of cardiology faculty development and director of the Structural Heart Program at Erlanger Health System in Chattanooga, Tennessee.
  • Coylewright is a Fellow of the American College of Cardiology and was selected for the ACC Emerging Faculty Program in 2014.

Megan Coylewright, MD, MPH, FACC, has been named editor of the American College of Cardiology’s CardioSmart patient engagement initiative, which aims to support the patient and clinician partnership to personalize care. Coylewright will serve a three-year term.

“The role of editor of CardioSmart is an ideal blend of my daily clinical work performing transcatheter valve repair and replacement, research in shared decision making, and our community and nationally-based efforts to ensure we are using best practices in promoting diversity, inclusion and belonging in all that we do,” Coylewright said. “I am thrilled to work with the talented staff of CardioSmart. Together, we will partner with patients and the cardiovascular care team to further embed the patient voice in our daily practices, scholarship, guidelines and clinical trials.”

Through CardioSmart.org, patients and clinicians can find information about heart conditions, resources to support important health care conversations and tools to build their partnership—not just on specific decisions, but over a lifetime. CardioSmart is a direct reflection of the ACC’s Core Values: Patient-Centered, Teamwork and Collaboration, and Professionalism and Excellence. As editor, Coylewright will be responsible for advising and ensuring clinical accuracy of the editorial content development on CardioSmart.org, as well as assist in developing innovative strategies to help the ACC best engage, educate and activate the diversity of cardiovascular patients in their care.

Trained as a structural interventional cardiologist, Coylewright is the vice chief of cardiology faculty development and director of the Structural Heart Program at Erlanger Health System in Chattanooga, Tennessee. Coylewright focuses on minimally invasive treatment options for heart disease. She is also committed to creating partnerships between clinicians and patients using shared decision-making to ensure patients meaningfully participate in informed care decisions that are right for them. Coylewright champions efforts both locally and nationally to increase diversity and inclusion in interventional cardiology, as well as amongst patients enrolled in clinical trials.

Prior to her current role, Coylewright completed her medical school, residency and public health training at Johns Hopkins University in Baltimore. While there, she also served as the health disparities coordinator at the Baltimore City Public Health Department. She completed an additional five years of training in cardiology, interventional cardiology and structural heart interventions at Mayo Clinic.

Coylewright is a Fellow of the American College of Cardiology and was selected for the ACC Emerging Faculty Program in 2014. She has made many contributions to the ACC thus far, including leading the shared decision-making section of the Championing Care initiative for patients with severe aortic stenosis from 2012-2014; serving on the Annual Scientific Session Program Committee from 2019-2022; and co-authoring the Diversity, Equity, Inclusion and Belonging section of the 2020 American Heart Association and American College of Cardiology Consensus Conference on Professionalism and Ethics report.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."

Sedana Medical Completes Patient Recruitment for INSPiRE-ICU 1 Clinical Trial in the US

Peter Sackey further elaborated: "Once the 30-day follow-up of all patients is complete, we will enter into an intense phase of final monitoring, data cleaning and transfer to our statistician team for analysis. In parallel, the long-term outcomes at 3 and 6 months will be collected centrally by the Critical Illness, Brain Dysfunction, and Survivorship team at Vanderbilt Medical Center. With this parallel approach, we expect topline results in the autumn of this year and a swift regulatory submission in Q1, 2025".

Health / Lifestyle

Articles of Interest

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy